BALAXI PHARMACEUTICALS LIMITED — Updates

Balaxi Pharmaceuticals has informed stock exchanges about the receipt of a Report on Real-Time Auditing (RTA) for the re-lodgement of physical share transfer requests. This report covers the period ending August 2026 and is part of the company's ongoing compliance with regulatory requirements regarding physical share certificates.

This update is a routine corporate disclosure and does not indicate any specific operational changes or financial results. For investors, it primarily serves as a confirmation that the company is maintaining proper records for physical share transactions. It ensures transparency in the handling of share certificates, which is essential for the smooth transfer of ownership.

Investors holding physical shares should monitor this process to ensure their transfer requests are being processed correctly. The company's adherence to these regulatory filings is a positive sign of corporate governance, though it does not directly impact the stock's market performance or valuation at this time.